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The association between hearing and balance disorders 
with migraine is known since the times of the ancient Greeks, 
when Aretaeus from Cappadocia in 131 B.C, made an accurate 
and detailed description of this occurrence during a migraine 
episode. We present a broad review of migraine neurotological 
manifestations, using the most recent publications associated 
with epidemiology, clinical presentation, pathophysiology, 
diagnostic methods and treatment for this syndrome. Aim: to 
describe the clinical entity: “Migraine associated with auditory-
vestibular dysfunction” in order to help otorhinolaryngologists 
and neurologists in the diagnosis and management of such 
disorder. Final Remarks: There is a strong association 
between neurotological symptoms and migraine, and the 
auditory-vestibular dysfunction-associated migraine is the 
most common cause of spontaneous episodic vertigo (non-
positional). Symptoms may vary broadly among patients, 
making it a diagnostic challenge to the otorhinolaryngologist. 
This entity usually presents with positional or spontaneous 
vertigo spells, lasting for seconds or days, associated 
with migraine symptoms. A better understanding of the 
relationship between central vestibular mechanisms and 
migraine mechanisms, besides the discovery of ionic channel 
disorders in some cases of migraine, ataxia and vertigo, may 
lead to a better understanding of migraine pathophysiology 
associated with audio-vestibular disorder.
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INTRODUCTION
The association between hearing/balance disorders 
and migraine has been recognized since ancient Greece, 
when in 131 a.C., Aretaeus of Cappadocia described preci-
sely and in detail the occurrence of both conditions during 
a migraine crisis.1 In 1861, Prosper Ménière published a 
classical paper describing the symptoms of Ménière Syn-
drome (MS) in migraine patients.2 In 1873, Liveing reported 
a clear association between vertigo and migraine, which 
has since been also reported by various authors: Gowers 
et al., 1907; Symonds et al., 1926; Graham et al., 1968; and 
Kayan et al., 1984. These papers defined the concept that 
vertigo, hearing loss and tinnitus were part of the symp-
toms that some migraine patients presented.3-6 
In 1961, Bickerstaff, introduced the Basilar Migraine 
concept, which is characterized by occipital headache 
with signs or symptoms of cranial nerve and/or brainstem 
dysfunction, such as: disorders of vision, vertigo, ataxia, 
speech disorders, tinnitus, and sensory alterations on 
extremities.7
Various types of balance disorders have been repor-
ted during headache crises in migraine patients, such as 
rotational vertigo, positional vertigo, dizziness, intolerance 
to head movement, and other less common findings.4,8-16
Classical migraine patients presenting kinetosis in 
childhood or as adults appear to be more susceptible to 
migraine crises.4,16,-21.
Reported auditory disorders include phonophobia 
(intolerance to loud noise) and hyperacusis (abnormal 
noise sensitivity), first described by Tissot in 1778 (cited 
by Sachs et al., 1970), which may be related to headache-
induced stress.1
Currently, otologists and neurologists have recei-
ved patients presenting a clinical picture of migraine-like 
headaches, episodes of dizziness, at times even vertigo, 
aural fullness, auditory symptoms and tinnitus. These 
patients have led to a description of a new clinical entity, 
which has been given various names, including: migraine-
associated dizziness, migraine-related dizziness, migraine-
related vertigo, migrainous vertigo, migraine-anxiety re-
lated dizziness and migraine-associated cochleovestibular 
dysfunction.6,14,20,22-24
Given the paucity of references on this theme in 
Portuguese, he authors have chosen the name “migraine-
related auditory-vestibular dysfunction” The reason for 
this is that many patients present vestibular findings that 
differ from the true concept of vertigo; symptoms may 
range from a feeling of unbalance to instability, vertigo, 
and in some cases even cochlear disorders such as tinnitus, 
intermittent dysacusis and auricular fullness.
The pathophysiology of migraine-related auditory-
vestibular symptoms has not been fully clarified, but its 
clinical manifestation is varied.23 These patients usually pre-
sent symptoms ranging from episodes of dizziness to acute 
vertigo and constant unbalance, sensorineural hearing loss, 
tinnitus, aural fullness and intermittent dysacusis. These 
symptoms are often mistaken with the classical symptoms 
of MS. It is, therefore, a syndrome that lies between migrai-
ne with aura and MS; the differential diagnosis between 
these three entities is often a major challenge (Figure 1 
and Table 1), requiring significant healthcare professional 
experience and knowledge about their clinical, diagnostic 
and therapeutic aspects.22,25-27
Figure 1. Relations among the syndromes.
OBJECTIVES
The purpose of this study was to describe the clini-
cal entity “migraine-related auditory-vestibular dysfunction” 
to support otorhinolaryngologists and neurologists in the 
diagnosis and clinical management of this syndrome.
The authors reviewed the literature and the clinical 
experience of a North-American tertiary reference hospital 
for otoneurological disorders, looking at signs and symp-
toms and vestibular clinical findings for the diagnosis and 
treatment of these patients.
    
Epidemiology
Epidemiological data have underlined the increasing 
importance of migraine-related auditory-vestibular dys-
function in recent years. Recent papers have shown that 
migraine is one of the diseases with the highest morbidity 
worldwide; it affects about 4-6.5% of men and 11.2-18.2% 
of women both in the USA and in Europe.26,28 A correlation 
between migraine-related auditory-vestibular dysfunction 
and MS shows that the incidence of MS in the USA is about 
5-15 for each 100,000 individuals (0.015%). Based on these 
numbers, we may assume that if 1% of migraine-related 
auditory-vestibular dysfunction patients presented suffi-
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cient episodes of vertigo to seek medical help, physicians 
would diagnose 15 times more patients with this entity 
compared to MS.25 The international medical literature pays 
insufficient attention to migraine-related auditory-vestibular 
dysfunction, suggesting that this condition is frequently not 
diagnosed. Lipton et al. (2002) studied a sample of 4,376 
patients and revealed that migraine affects individuals in 
their most economically productive age group, namely 
30-39 years (25.7%), 40-49 years (24.4%) and 18-29 years 
(22.3%), which underlies the importance of correctly diag-
nosing and treating this condition.28
This connection is even more evident in epidemio-
logical studies of migraine patients: 28 to 36% of patients 
present associated dizziness, and 25 to 26% present verti-
go.26 Similarly, 36% of patients that complain of dizziness 
may fit into the clinical criteria for migraine, and 61% of 
patients with vertigo of unknown causes may also fit into 
the clinical criteria for migraine.24 In a case-control study 
of 10 patients, Furman et al. revealed that dizziness and 
vertigo occur in 54% of migraine patients and in only 
30% of patients with headaches of other origins, such as 
tension-type headaches,23,29 reinforcing the hypothesis 
of comorbidity between migraine and cochleovestibular 
disorders.
 
Clinical and Diagnostic Findings
Many individuals, and even healthcare professio-
nals, still think that migraine is unilateral, pulsatile hea-
dache associated with visual and auditory disorders, and 
usually associated with nausea and vomiting. This concept 
remains correct and is the best know aspect of migraine 
with aura, according to the International Headache Socie-
ty (IHS) criteria that were described in 1988.30 Currently, 
however, medical researchers have widened the scope 
of migraine, describing it as a global sensorial perceptive 
alteration in an individual. Any sensorial perception-related 
symptom may be described, including hearing, olfactive, 
visual, tactile, gustatory and postural disorders.6,23,28
 
Differentiating migraine with aura from migraine with 
auditory-vestibular disorders
Duration of headache is the first point to note 
when differentiating migraine-related auditory-vestibular 
dysfunction from classical migraine with aura. In classical 
migraine, symptoms may last from a few seconds to 60 
minutes, while in migraine-related auditory-vestibular 
dysfunction cases, symptoms generally last hours, days 
or even months. Adult patients with migraine-associated 
vestibular dysfunction usually report spontaneous or 
positional vertigo, occasionally initiating as spontaneous 
vertigo and eventually becoming positional vertigo.6 An 
important point is that the duration of this type of posi-
tional vertigo differs from that seen in benign paroxysmal 
positional vertigo (BPPV). Patients with migraine-related 
cochleovestibular dysfunction usually describe vertigo 
while the head is in the due trigger position, contrary to 
what occurs in BPPV, in which vertigo lasts only a few 
seconds. Intolerance to movement is another characteristic 
feature of migraine-related auditory-vestibular dysfunction, 
which is very similar to the clinical findings of kinetosis 
(feeling of unbalance, illusion of movement and nausea 
worsened by head movements).31 Visual vertigo induced 
by movie screens, by lighting such as that found in stores 
and shopping malls and by computer screens is typical of 
migraine-related auditory-vestibular dysfunction.
Vertigo attacks may vary widely, lasting from mi-
nutes to two hours (46.4%), and many hours or weeks 
(30.4%).22 Some individuals may require weeks to months 
to recover fully from an attack of vertigo. Such attacks 
may occur at intervals of days, weeks, months, or even 
Chart 1. Association between symptoms and syndromes.
Patients with Meniere’s disease Patients with migraine with aura
Migraine symptoms Meniere-like symptoms
Headache Vertigo and Floating Hearing Loss in the low frequencies
Hinchcliffe et al, 1963 Atkinson et al, 1962
Eklund et al, 1999 Kayan et al, 1984
Ceranic et al, 2006 Olsson et al, 1991
Lopes et al, 2006 Baloh et al, 1997 & 2000
Radtke et al, 2002
Neuhauser et al, 2001 & 2004
Aura-like symptoms Ear fullness and tinnitus
Kentala et al, 1997 Sand et al, 2000
Baloh et al, 1999 Baloh et al, 2000
Radtke et al, 2002
Neuhauser et al, 2001 & 2004
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years. Differentiating migraine-related auditory-vestibular 
dysfunction from migraine with aura may be more difficult 
when clinical findings last between 5 and 60 minutes,.
A careful clinical history is the best weapon for 
physicians to diagnose migraine-related auditory-vestibular 
dysfunction. Neuhauser et al published the clinical criteria 
for diagnosing this entity in a classical paper based on 
the IHS guidelines for diagnosing migraine.32 This paper, 
which has probably contributed most to the diagnostic 
standardization of that clinical entity, defined criteria for 
migraine-related vestibular disease for the defined and 
probable forms. These authors used the method of as-
sessing three groups of patients: the first group included 
outpatient subjects presenting with vestibular disorders 
(n=200), the second group included patients with migraine 
(n=200) as defined by IHS criteria, and the third group 
included patients from the orthopedics unit of the same 
hospital that belonged to the same age group as group 
1 patients (control group / n=200). After analyzing these 
groups, the authors proposed the criteria for classifying 
migraine-related auditory-vestibular dysfunction that are 
presented on Table 2.
These criteria have been adopted by most of the 
authors and international clinical units in this area in an 
attempt to standardize the diagnosis of migraine-related 
auditory-vestibular dysfunction.14-16,21-23,26,33,35 More recen-
tly, Marcus et al. developed a questionnaire based on 
Neuhauser’s criteria to serve as a screening tool for pa-
tients with vestibular conditions in which a diagnosis of 
migraine-related vestibular disease is considered.33
Many authors have applied vestibular and audi-
tory testing in patients diagnosed with migraine-related 
auditory-vestibular dysfunction in an attempt to establish 
a pattern for vestibular findings that would support 
the diagnosis of this condition. Another aim of vesti-
bular testing would be to differentiate migraine-related 
auditory-vestibular dysfunction from the initial stages of 
MS.16,20,22,23,36,37,38
 
Differentiating migraine-related auditory-vestibular dys-
function from Ménière’s syndrome (MS)
Battista analyzed the audiometric findings of 76 
patients with migraine-related auditory-vestibular dys-
function n and 34 patients diagnosed with MS. Results 
Chart 2. Classification of Migraine associated with Vestibular-Auditory Dysfunction.
Classification of Migraine associated with Vestibular-Auditory Dysfunction.
Established
• Episodes of vestibular symptoms, of moderate to severe intensity (rotational vertigo, positional vertigo, other sensations of head movement 
intolerance)
• Migraine according to criteria from the International Headache Society, 2001.
• At least one of the following migraine symptoms during at least two dizziness spells:
          Headache, photophobia, phonophobia, visual disorders and other aura symptoms
• Ruling out other causes after clinical investigation
Probable
• Moderate to severe vestibular symptom spells (rotational vertigo, positional vertigo, other sensations of intolerance to head movement)
• According to the IHS, at least one of the following signs for migraine patients: 
         Migraine symptoms during at least two vertigo spells;
         “Trigger” signs for migraine spells with some food stuff;
         Sleep disorders;
         Hormonal changes; 
         Positive response to anti-migraine drugs.
• Rule out other established cause of dizziness after due diagnostic investigation. 
“Mild” vestibular symptoms were defined as those that do not interfere with the individual’s daily activities; “moderate” when they interfere in 
daily activities, but do not prevent them, and “severe” when the individual is prevented from performing his/her daily activities.
Please bear in mind that non-vestibular dizziness, such as orthostatic hypotension, was not included. 
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revealed that although there were descriptions in the 
literature of auditory disorders in patients with migraine-
related auditory-vestibular dysfunction, most of them had 
normal hearing, different from patients with MS (including 
intermittent hearing loss as part of the typical clinical 
picture of MS).22
Furman et al. studied patients with migraine-related 
auditory-vestibular dysfunction by using a battery of ves-
tibular tests and found altered vestibular-spinal function 
tests in posturography. Balance was increased in patients 
with migraine-related auditory-vestibular dysfunction com-
pared to both control groups, particularly in the Sensory 
Organization Test 4, 5 and 6 (Equitest®); the same patients 
had normal oculomotor movements and caloric responses 
during vertigo-free periods,23,29 and more frequently altered 
rotatory chair test results compared to abnormal findings 
on electronystagmography (ENG).20,37
Dimitri et al. analyzed multiple variables in an at-
tempt to establish a difference between migraine-related 
auditory-vestibular dysfunction and MS based on vestibular 
testing. The authors concluded that decreased vestibular 
responses in caloric testing and altered rotatory chair tes-
ting were significant in 91% of cases when differentiating 
migraine-related auditory-vestibular dysfunction and MS.38 
In summary, there appears to be no typical pattern in 
vestibular testing for establishing a diagnosis of migraine-
related auditory-vestibular dysfunction, which reinforces 
even further the need for a carefully taken clinical history. 
Vestibular testing such as ENG, the rotatory chair test, elec-
trocochleography (ECoG), and vestibular myogenic evoked 
potentials (VEMP) may support a diagnostic hypothesis 
raised in the clinical history. Progressive hearing loss is 
still the beset method for differentiating migraine-related 
auditory-vestibular dysfunction and MS.
 
Treatment
Having made a diagnosis of migraine-related audi-
tory-vestibular dysfunction, the next step is counseling of 
patients. In general, patients with this condition respond 
positively to well-established therapy for migraine.21,39,40 
The first step in controlling the symptoms is to persuade 
patients to adopt the so-called “migraine lifestyle,” which 
includes dietary changes, regular exercise, and regular 
sleep. Dietary changes include decreasing or eliminating 
the use of aspartame, chocolate, caffeine and alcohol.40 
It is also essential to exercise regularly, to decrease stress 
and to improve sleep.39 If these behavioral measures are 
unsuccessful, medication may be used for controlling ver-
tigo episodes. There are the migraine-suppressing drugs 
(benzodiazepines, beta-blockers, tricyclic antidepressants, 
etc.) and the migraine-aborting drugs (mainly sumatrip-
tan). Migraine-aborting drugs are an excellent option for 
treating migraine; however, in migraine-related auditory-
vestibular symptoms, such drugs are generally not used 
because crises of vertigo usually occur as a headache 
aura.13 Thus, migraine-suppressing drugs are more used 
in otoneurology.
Possibly the most relevant data in the therapy of 
migraine-related auditory-vestibular symptoms were pu-
blished in 2002 in a retrospective study that revealed that 
over 72% of patients improved or had complete remission 
of symptoms after step-by-step treatment was introdu-
ced.21 This treatment consists initially of changing the diet, 
followed by migraine-suppressing drugs such as low-dose 
tricyclic antidepressants, calcium channel blockers and 
beta-blockers.
The efficacy of drugs used in migraine-related 
auditory-vestibular dysfunction therapy is directly related 
with the ability of such drugs in combating or aborting he-
adaches.13 Clinical randomized, prospective, double-blind, 
placebo-controlled studies for comparing the efficacy of 
various drugs in the treatment exclusively of migraine-
related auditory-vestibular symptoms have not yet been 
published in the literature. Thus, otoneurologists use their 
personal experience in managing this syndrome.
The authors emphasize the idea that, when mana-
ging correctly headaches associated with auditory-vestibu-
lar symptoms, physicians should be aware of side-effects 
and reactions to drugs that otorhinolaryngologists do not 
prescribe regularly in everyday practice. It is therefore wise 
to begin with the lowest pharmacological dose.
The first step in treatment is to start with behavioral 
measures such as an adequate diet, good sleeping habits, 
regular physical exercise, and a decrease in stress levels 
during at least one month. Drug therapy is initiated if pa-
tients continue with regular episodes of migraine-related 
auditory-vestibular symptoms. Preferred drugs are tricyclic 
antidepressants, especially nortryptiline (10 mg/day) at 
night before sleeping, to minimize the main side effects 
(drowsiness and xerostomia). The initial dose should be 
maintained for two weeks, after which it is increased if 
migraine crises persist. Most of the patients benefit from 
a dose between 30 and 70 mg/day without presenting 
side effects.
Beta-blockers are the second drugs of choice for 
the authors, especially propanolol. The initial dose is 40 
mg/day; most patients end up taking around 80mg/day. It 
is important to note that most of the patients with a diag-
nosis of migraine-related auditory-vestibular dysfunction 
are young women; these patients tend to present arterial 
hypotension, which makes beta-blockers an added risk. 
It is clear that therapy for each patient should be approa-
ched individually, taking into account factors such as age, 
sex, comorbidities, etc., so that the lowest dose capable 
of controlling the disease may be used, thus decreasing 
significant side effects.
Reploeg et al. demonstrated that 100% of migraine-
related auditory-vestibular dysfunction patients reported 
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some improvement in vertigo and unbalance after initia-
ting one of these therapies.21 Another study involving 53 
migraine-related auditory-vestibular dysfunction patients 
revealed that the efficacy of drugs in controlling vestibular 
symptoms was directly proportional to their headache-
relieving ability.13 A current frequently debated theme in 
the treatment of this condition is the true importance of 
vestibular rehabilitation therapy. Various authors have 
published papers demonstrating the benefits of vestibular 
rehabilitation therapy in migraine-related auditory-vestibu-
lar dysfunction patients.34,39,41,42.
FINAL COMMENTS
Otoneurologists worldwide have studied migraine-
related auditory-vestibular dysfunction, given its clinical 
manifestations that are similar to those found in a variety 
of other otoneurological diseases, particularly MS.
Being a recently described syndrome, most otorhi-
nolaryngologists are not prepared for diagnosing this con-
dition, which should be part of the differential diagnosis of 
vertigo and of the management of migraine patients.
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